Cancer-Associated Fibroblasts: Master Tumor Microenvironment Modifiers
Cancers · 22.03.2023 · 15 (6) · 1899
DOI: 10.3390/cancers15061899 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 22.03.2023. Verfasst von Kellen Wright und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, University of Kansas Medical Center, Kansas City, KS 66160, USA. Die Arbeit wurde bisher 198-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, University of Kansas Cancer Center.
Abstract (Originalsprache)
Cancer cells rely on the tumor microenvironment (TME), a composite of non-malignant cells, and extracellular matrix (ECM), for survival, growth, and metastasis. The ECM contributes to the biomechanical properties of the surrounding tissue, in addition to providing signals for tissue development. Cancer-associated fibroblasts (CAFs) are stromal cells in the TME that are integral to cancer progression. Subtypes of CAFs across a variety of cancers have been revealed, and each play a different role in cancer progression or suppression. CAFs secrete signaling molecules and remodel the surrounding ECM by depositing its constituents as well as degrading enzymes. In cancer, a remodeled ECM can lead to tumor-promoting effects. Not only does the remodeled ECM promote growth and allow for easier metastasis, but it can also modulate the immune system. A better understanding of how CAFs remodel the ECM will likely yield novel therapeutic targets. In this review, we summarize the key factors secreted by CAFs that facilitate tumor progression, ECM remodeling, and immune suppression.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology, University of Kansas Medical Center, Kansas City, KS 66160, USA.
- Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS 66160, USA.
- Department of Cell Biology and Physiology, University of Kansas Medical Center, Kansas City, KS 66160, USA.
ORCID-Profile: Thuc Ly
Förderung
- NCI NIH HHS
- NIH HHS
- University of Kansas Cancer Center
- philanthropic donations
Zitieren
APA
Wright, K., Ly, T., Kriet, M., Czirok, A., & Thomas, S. M. (2023). Cancer-Associated Fibroblasts: Master Tumor Microenvironment Modifiers. Cancers, 15(6), 1899. https://doi.org/10.3390/cancers15061899
Vancouver
Wright K, Ly T, Kriet M, Czirok A, Thomas SM. Cancer-Associated Fibroblasts: Master Tumor Microenvironment Modifiers. Cancers. 2023;15(6):1899. doi:10.3390/cancers15061899
BibTeX
@article{Wright2023,
author = {Wright, Kellen and Ly, Thuc and Kriet, Matthew and Czirok, Andras and Thomas, Sufi Mary},
title = {Cancer-Associated Fibroblasts: Master Tumor Microenvironment Modifiers},
journal = {Cancers},
year = {2023},
volume = {15},
number = {6},
pages = {1899},
doi = {10.3390/cancers15061899}
}
EUVIMED